ScyllaCharacterization-package: ScyllaCharacterization: Characterize all emerging drug...
In ohdsi-studies/ScyllaCharacterization: Characterize all emerging drug therapies used in COVID-19 treatment
Description
The aim of this study is to characterize all emerging drug therapies used in COVID-19 treatment. Specifically, the study aims to chararacterize: 1) Treatments administered during hospitalization and prior to intensive services, 2) Treatments administered during hospitalization after initiating intensive services, 3) Treatments administered after COVID-19 positive testing or diagnosis in outpatient setting without prior hospitalization.
See Also
Useful links:
-
Report bugs at https://github.com/OHDSI/ScyllaCharacterization/issues
ohdsi-studies/ScyllaCharacterization documentation built on April 23, 2021, 4:07 p.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Description
The aim of this study is to characterize all emerging drug therapies used in COVID-19 treatment. Specifically, the study aims to chararacterize: 1) Treatments administered during hospitalization and prior to intensive services, 2) Treatments administered during hospitalization after initiating intensive services, 3) Treatments administered after COVID-19 positive testing or diagnosis in outpatient setting without prior hospitalization.
See Also
Useful links:
Report bugs at https://github.com/OHDSI/ScyllaCharacterization/issues
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.